financial statement

SINGAPORE (Feb 27): Nam Cheong announced earnings of RM9.7 million for the 4Q ended Dec 2018, reversing from its loss of RM987.5 million in 4Q17 mainly a result of a waiver of debts.

SINGAPORE (Feb 25): Raffles Medical Group (RMG) announced $71.1 million in earnings for FY18, rising a marginal 0.4% from $70.8 million in FY17 as higher tax expenses and additional depreciation from the recently-completed Raffles Specialist Centre contin

SINGAPORE (Feb 21): Sembcorp Industries reported earnings of $106 million for the 4Q ended Dec 2018, representing a 10% decline from restated 4Q17 earnings of $118 million as the Marine segment continued to impact the absorption of overhead costs.

SINGAPORE (Feb 21): City Developments recorded earnings of $77.9 million for 4Q18, down 54.7% from $171.9 million a year ago on lower revenue and higher expenses.

SINGAPORE (Feb 20): Technologies company CSE Global declared earnings of $4.9 million for the 4Q ended December, reversing back into profitability from its restated loss of $39.1 million due to improved margins.

SINGAPORE (Feb 20): China Everbright Water has announced FY18 earnings of HK$676.5 million ($116.5 million), growing 32% y-o-y from HK$513.4 million a year ago on the back of higher revenue.    

SINGAPORE (Feb 20): CapitaLand Limited reported 4Q18 earnings of $475.7 million, up 71.2% on-year from its restated earnings of $277.8 million due to better operating performance, as well as higher gains from asset recycling and revaluation of investment

SINGAPORE (Feb 19): BreadTalk Group delivered earnings of $15.2 million for FY18, declining 29.9% from its earnings of $21.7 million for FY17 despite booking revenue growth for the year.

SINGAPORE (Feb 19): Singapore Medical Group (SMG) posted a 17.2% rise in 4Q18 earnings to $2.9 million from $2.5 million a year ago, driven by increased revenue contributions from the health and diagnostic & aesthetic business segments.